The MHRA will now discuss the concerns, related to the wellbeing of children and young people with gender dysphoria, with trial sponsor King’s College London next week
Notifications can be managed in browser preferences.
Swipe for next article
The MHRA will now discuss the concerns, related to the wellbeing of children and young people with gender dysphoria, with trial sponsor King’s College London next week
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Plans for a puberty blockers trial were announced in 2024 following the publication of the Cass Review.
Study set to delay recruitment after warning participants should be a minimum of 14 years old
Those taking part in the study will be children under 16 who are going through puberty.
Multi-year studies announced after Cass review found ‘insufficient evidence’ about effects on children with gender dysphoria
Letters arguing research could harm participating children sent to medical regulators, health secretary and NHS
NHS to investigate Brighton GP surgery ‘to identify harm’ following revelation
